Sonographically guided percutaneous @entity1463 using 1% @entity5324 in the treatment of XXXX .

@entity1095 @entity1 @entity455 @entity2758 @entity1463 @entity2696 @entity80 @entity1211 @entity5324 @entity1462
PURPOSE: The aim of this prospective study was to assess the safety and efficacy of sonographically guided percutaneous injection of 1% @entity5324 for @entity1463 of @entity1095 . METHODS: @entity1 with @entity1462 of soft tissues were invited to enroll in the study. Gray-scale and color Doppler sonography were performed to determine the texture, margins, and size of the lesions and to determine whether high-velocity blood flow was present. Using real-time sonographic guidance, lesions were punctured with a 20/21-gauge spinal needle. When possible, venous return was occluded before injection. For each injection, 1-6 ml of 1% @entity5324 was injected into 1 or more sites within the lesion. The sclerosing agent was not aspirated after injection. Repeat radiography was performed 1 month after each injection session. The procedure was repeated if the @entity1 did not have a complete response, defined as an 80% or greater decrease in the volume of the lesion or resolution of the presenting symptoms. RESULTS: Of the 15 @entity1 enrolled, 9 had @entity1211 , 3 had @entity2696 , 1 had a recurrent @entity80 , 1 had a @entity1211 , and 1 had an @entity2758 of the pinna. Each @entity1 received 1-20 injections of 1% @entity5324 (mean +/- standard deviation, 3.3 +/- 4.8 injections). This treatment resulted in a complete response of 7 @entity1211 , 3 @entity2696 , and the @entity2758 and partial response of 2 @entity1211 , the recurrent @entity80 . Only minor complications occurred. CONCLUSIONS: Sonographically guided percutaneous injection of 1% @entity5324 for @entity1463 of peripheral @entity455 is simple, effective, and safe. This technique is especially effective in cases of soft tissue @entity1211 and @entity2696 .
